These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 9400615)

  • 1. Increasing the ratio of PP2A core enzyme to holoenzyme inhibits Tat-stimulated HIV-1 transcription and virus production.
    Ruediger R; Brewis N; Ohst K; Walter G
    Virology; 1997 Nov; 238(2):432-43. PubMed ID: 9400615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A protein phosphatase from human T cells augments tat transactivation of the human immunodeficiency virus type 1 long-terminal repeat.
    Bharucha DC; Zhou M; Nekhai S; Brady JN; Shukla RR; Kumar A
    Virology; 2002 Apr; 296(1):6-16. PubMed ID: 12036313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 tat transcriptional activity is regulated by acetylation.
    Kiernan RE; Vanhulle C; Schiltz L; Adam E; Xiao H; Maudoux F; Calomme C; Burny A; Nakatani Y; Jeang KT; Benkirane M; Van Lint C
    EMBO J; 1999 Nov; 18(21):6106-18. PubMed ID: 10545121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of the major 5' splice site renders a CMV-driven HIV-1 proviral clone Tat-dependent: connections between transcription and splicing.
    Bohne J; Kräusslich HG
    FEBS Lett; 2004 Apr; 563(1-3):113-8. PubMed ID: 15063733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of the HIV-1 LTR as a promoter of negative sense transcription.
    Bentley K; Deacon N; Sonza S; Zeichner S; Churchill M
    Arch Virol; 2004 Dec; 149(12):2277-94. PubMed ID: 15338321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence elements downstream of the human immunodeficiency virus type 1 long terminal repeat are required for efficient viral gene transcription.
    Liang C; Li X; Quan Y; Laughrea M; Kleiman L; Hiscott J; Wainberg MA
    J Mol Biol; 1997 Sep; 272(2):167-77. PubMed ID: 9299345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-kappaB and the Tat transactivator.
    Roof P; Ricci M; Genin P; Montano MA; Essex M; Wainberg MA; Gatignol A; Hiscott J
    Virology; 2002 Apr; 296(1):77-83. PubMed ID: 12036319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of the human immunodeficiency virus type-1 long terminal repeat by the c-Myc oncoprotein.
    Stojanova A; Caro C; Jarjour RJ; Oster SK; Penn LZ; Germinario RJ
    J Cell Biochem; 2004 May; 92(2):400-13. PubMed ID: 15108364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proteasome regulates HIV-1 transcription by both proteolytic and nonproteolytic mechanisms.
    Lassot I; Latreille D; Rousset E; Sourisseau M; Linares LK; Chable-Bessia C; Coux O; Benkirane M; Kiernan RE
    Mol Cell; 2007 Feb; 25(3):369-83. PubMed ID: 17289585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tat-dependent repression of human immunodeficiency virus type 1 long terminal repeat promoter activity by fusion of cellular transcription factors.
    Zhao C; Chen Y; Park J; Kim JB; Tang H
    Biochem Biophys Res Commun; 2004 Sep; 322(2):614-22. PubMed ID: 15325274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of Tat-associated kinase-independent transcriptional elongation from the human immunodeficiency virus type-1 long terminal repeat by a cellular enhancer.
    West MJ; Karn J
    EMBO J; 1999 Mar; 18(5):1378-86. PubMed ID: 10064603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperativity between Rad51 and C/EBP family transcription factors modulates basal and Tat-induced activation of the HIV-1 LTR in astrocytes.
    Chipitsyna G; Sawaya BE; Khalili K; Amini S
    J Cell Physiol; 2006 Jun; 207(3):605-13. PubMed ID: 16511829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator.
    Marcello A; Zoppé M; Giacca M
    IUBMB Life; 2001 Mar; 51(3):175-81. PubMed ID: 11547919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
    Nevado J; Tenbaum SP; Castillo AI; Sánchez-Pacheco A; Aranda A
    J Mol Endocrinol; 2007 Jun; 38(6):587-601. PubMed ID: 17556530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Luman, a new partner of HIV-1 TMgp41, interferes with Tat-mediated transcription of the HIV-1 LTR.
    Blot G; Lopez-Vergès S; Treand C; Kubat NJ; Delcroix-Genête D; Emiliani S; Benarous R; Berlioz-Torrent C
    J Mol Biol; 2006 Dec; 364(5):1034-47. PubMed ID: 17054986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of PP2A by LIS1 increases HIV-1 gene expression.
    Epie N; Ammosova T; Turner W; Nekhai S
    Retrovirology; 2006 Oct; 3():65. PubMed ID: 17018134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dephosphorylation of CDK9 by protein phosphatase 2A and protein phosphatase-1 in Tat-activated HIV-1 transcription.
    Ammosova T; Washington K; Debebe Z; Brady J; Nekhai S
    Retrovirology; 2005 Jul; 2():47. PubMed ID: 16048649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separation of PP2A core enzyme and holoenzyme with monoclonal antibodies against the regulatory A subunit: abundant expression of both forms in cells.
    Kremmer E; Ohst K; Kiefer J; Brewis N; Walter G
    Mol Cell Biol; 1997 Mar; 17(3):1692-701. PubMed ID: 9032296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does HIV-1 Tat induce a change in viral initiation rights?
    Cullen BR
    Cell; 1993 May; 73(3):417-20. PubMed ID: 8490957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.